Cargando…
Women’s perspectives on ovulation induction with or without IUI as treatment for normogonadotrophic anovulation: a discrete choice experiment
STUDY QUESTION: What are the treatment preferences of women with normogonadotrophic anovulation treated with ovulation induction with or without intrauterine insemination (IUI)? SUMMARY ANSWER: Women with normogonadotrophic anovulation differ in their treatment preference; half of them base their pr...
Autores principales: | Weiss, N S, Schreurs, A M F, van der Veen, F, Hompes, P G A, Lambalk, C B, Mol, B W, van Wely, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276642/ https://www.ncbi.nlm.nih.gov/pubmed/30895235 http://dx.doi.org/10.1093/hropen/hox021 |
Ejemplares similares
-
Gonadotrophins or clomiphene citrate in women with normogonadotropic anovulation and CC failure: does the endometrium matter?
por: Bordewijk, E M, et al.
Publicado: (2020) -
The M-OVIN study: does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate – a randomised controlled trial
por: Nahuis, Marleen J, et al.
Publicado: (2013) -
Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women
por: Nahuis, Marleen, et al.
Publicado: (2010) -
Cost-effectiveness of ovarian stimulation agents for IUI in couples
with unexplained subfertility
por: van Eekelen, R, et al.
Publicado: (2021) -
Endometrial thickness as a biomarker for ongoing pregnancy in IUI for unexplained subfertility: a secondary analysis
por: Danhof, N A, et al.
Publicado: (2020)